Japan Intellectual Property Rights: METHOD OF TREATING TUMOR BY COMBINATION OF IL-7 PROTEIN AND IMMUNE CHECKPOINT INHIBITOR

Japan, July 31 -- NEOIMMUNETECH INC,GENEXINE INC has got intellectual property rights for 'METHOD OF TREATING TUMOR BY COMBINATION OF IL-7 PROTEIN AND IMMUNE CHECKPOINT INHIBITOR.' Other related details are as follows:

Application Number: JP,2024-141869

Category (FI): A61P11/04,A61P13/08,A61P13/10,A61P13/12,A61P43/00,105,A61P35/02,A61P27/02,A61P25/00,A61K47/02,A61K47/22,A61K38/20,A61K45/00,A61P35/00,A61P37/04,A61P43/00,121,A61K39/395@D,A61K39/395@W,A61K39/395@N,A61P15/00,A61K47/12,A61P1/02,A61P1/04,A61P1/16,A61P1/18,C07K14/54,A61P5/14,C07K19/00,C07K16/28,A61K39/395@U,A61P11/00,A61K47/18,A61P21/00,A61P17/00,A61K47/26,A61P11/02,A61K9/08

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Aug. 23, 2024

Publicat...